Zimbabwe has rejected a major American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' demand for sensitive biological samples.
This rejection came to light after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "unbalanced".
A government spokesman later stated that the US was demanding access to biological samples for scientific study and commercial purposes but refused to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further negotiations to reach a deal acceptable to all parties so the nation's critical HIV treatment initiative can proceed.
Wider Implications
This development comes after a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.
Based on statements, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be available to our population should a new health crisis arise."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting systems already set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This framework is intended to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how future collaboration might be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that negotiations should continue given that much of the nation's Aids initiatives depended on external financing.
"In cases where specific concerns arise, including those involving information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group commented.
The halted deal highlights the complex challenges between receiving vital foreign assistance and safeguarding local interests in an ever more data-driven world.